Market Analysis:
Digital Pathology Marketwas valued at USD 383.1 million in 2016 and is projected to reach USD 1,045.41 Million by 2025, growing at a CAGR of 11.8% from 2016 to 2025.
Market Definition:
Digital pathology is an image-based information environment which is enabled by computer technology that allows for the management of information generated from a digital slide. Digital pathology is enabled in part by virtual microscopy, which is the practice of converting glass slides into digital slides that can be viewed, managed, and analyzed on a computer monitor. With the advent of Whole-Slide Imaging, the field of digital pathology has exploded and is currently regarded as one of the most promising avenues of diagnostic medicine in order to achieve even better, faster and cheaper diagnosis, prognosis and prediction of cancer and other important diseases.Medical centers are investing in the market to reduce the costs associated with drug trials and risks, and to get accurate results.
Sample Infographics:
1. Market Drivers
1.1 Increasing usage of digital pathology
1.2 Increased efforts to enhance lab ethics and quality
1.3 Increased cases of cancer and need in drug developments
1.4 Ease of consultation
1.5 Increased interest of government and market players on technology usage
2. Market Restraints
2.1 High implementation cost
2.2 Lack of IT specified guidelines
Market Segmentation:
Digital Pathology Marketis segmented on the basis of:
1. Digital Pathology Market, byType:
1.1 Human Pathology
1.2 Veterinary Pathology
2. Digital Pathology Market, by end user:
2.1 Pharmaceutical and Biotechnology Companies
2.2 Academic and Government Research Institutes
2.3 Hospitals
2.4 Others
3. Digital Pathology Market, Application :
3.1 Teleconsultation
3.2 Disease Diagnosis
3.3 Drug Discovery
3.4 Training and education
3.5 Others
4. Digital Pathology Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, Japan, India, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5Rest of the World
Competitive Landscape:
The major players in the market are as follows:
1. Leica Biosystems
2. Ventana Medical Systems
3. Hamamatsu Photonics
4. 3DHISTECH
5. Koninklijke Philips
6. Apollo Enterprise Imaging
7. XIFIN
8. Huron Digital Pathology
9. Visiopharm
10. Corista
11. Indica Labs
12. Objective Pathology Services
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Digital Pathology Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL DIGITAL PATHOLOGY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL DIGITAL PATHOLOGY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL DIGITAL PATHOLOGY MARKET, BY TYPE
5.1 Overview
5.2 Human Pathology
5.3 Veterinary Pathology
6 GLOBAL DIGITAL PATHOLOGY MARKET, BY END-USER
6.1 Overview
6.2 Pharmaceutical and Biotechnology Companies
6.3 Academic and Government Research Institutes
6.4 Hospitals
6.5 Others
7 GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION
7.1 Overview
7.2 Teleconsultation
7.3 Disease Diagnosis
7.4 Drug Discovery
7.5 Training and education
7.6 Others
8 GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
9 GLOBAL DIGITAL PATHOLOGY MARKETCOMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Leica Biosystems
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Ventana Medical Systems
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Hamamatsu Photonics
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 3DHISTECH
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Koninklijke Philips
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Apollo Enterprise Imaging
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 XIFIN
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Huron Digital Pathology
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Visiopharm
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Corista
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
10.11 Indica Labs
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments
10.12 Objective Pathology Services
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments
11 Appendix
11.1 Related Reports
Price : US$ 3500 |
Date : Dec 2024 |
Category : Services |
Pages : 165 |
Price : US$ 3500 |
Date : Dec 2024 |
Category : Services |
Pages : 167 |
Price : US$ 3500 |
Date : Dec 2024 |
Category : Services |
Pages : 167 |